首页 | 本学科首页   官方微博 | 高级检索  
     


Heart transplantation for cardiac light chain amyloidosis with subsequent autologous stem cell transplantation
Authors:Tomas Honek  Jan Krejci  Lenka Spinarova  Petr Hude  Petr Nemec  Zdenek Adam  Alzbeta Sirotkova  Vita Zampachova  Jiri Vitovec
Affiliation:1. International Clinical Research Center, Department of Cardiovascular Diseases, St. Anne''s University Hospital Brno and Masaryk University, Brno, Czech Republic;2. Center of Cardiovascular Surgery and Transplantation, International Clinical Research Center, St. Anne''s University Hospital Brno, Brno, Czech Republic;3. Department of Internal Medicine—Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic;4. First Department of Pathological Anatomy, St. Anne''s University Hospital Brno, Brno, Czech Republic
Abstract:Our report describes a case of 57-year-old man with manifest heart failure on the basis of cardiac amyloidosis, which was detected by endomyocardial biopsy. Due to the heart failure, the patient was unable to undergo myeloablative therapy. We changed our previous decision for conservative therapy of heart failure and the patient underwent heart transplantation. Autologous stem cell transplantation was performed 6 months later. After the successful stem cell transplantation, the serum free light chain lambda levels promptly decreased. One year later, their levels started again to increase. Chemotherapy was therefore initiated. The patient has now completed the seventh cycle of chemotherapy in good condition. The graft function is normal and the latest endomyocardial biopsy revealed no amyloid.
Keywords:Heart failure  Amyloidosis  Heart transplantation  Endomyocardial biopsy  Autologous stem cell transplantation
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号